Krystexxa 8MG
Ended Awarded
- Contract number
- 36C24524N0430
- Awardee
-
Horizon Therapeutics Usa, Inc. UEI SK1UK7S74GB3
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $74,538
Award facts
- Contract value 100% obligated
- $74,537.76 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- La Vergne, TN 37086, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price delivery order for KRYSTEXXA 8MG to the prime contractor, Horizon Therapeutics USA, Inc. This order, valued at $74,537.76, was placed against Horizon's existing Multiple Award Schedule (MAS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The delivery order has an April 17, 2024 completion date and will provide the specialized orphan drug to VHA hospitals and clinics across the country to support healthcare services for veterans. Horizon Therapeutics, a global biotechnology company, also holds an $18 million Blanket Purchase Agreement against the same Pharmaceuticals and Drugs MAS contract, allowing the VA to efficiently procure additional therapies such as Ravicti, Buphenyl, Procysbi and Actimmune through September 2024. The contract has no set-aside designation.
Quick answers
Who was awarded contract 36C24524N0430?
36C24524N0430 was awarded to Horizon Therapeutics Usa, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on April 17, 2024.
How much is contract 36C24524N0430 worth?
The government has obligated $74,538 on 36C24524N0430.
Is contract 36C24524N0430 an order under another contract?
Yes. 36C24524N0430 is a delivery order under 36F79719D0224, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24524N0430 competed?
The extent of competition for 36C24524N0430 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award